Literature DB >> 7406382

Drug therapy in renal failure: dosing guidelines for adults. Part II: sedatives, hypnotics, and tranquilizers; cardiovascular, antihypertensive, and diuretic agents; miscellaneous agents.

W M Bennett, R S Muther, R A Parker, P Feig, G Morrison, T A Golper, I Singer.   

Abstract

Data providing guidelines for drug use in adult patients with renal insufficiency are presented in tabular form with supporting references. The data are derived from the current medical literature. If specific information about a drug is unavailable or conflicting, emphasis is given to normal pharmacokinetic variables in arriving at recommendations for therapy. Nephrotoxicity or adverse effects in patients with renal disease are noted and adjustments for dialysis suggested.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7406382     DOI: 10.7326/0003-4819-111-3-286

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  13 in total

1.  Hypertension in the elderly.

Authors:  B Hutchison
Journal:  Can Fam Physician       Date:  1981-10       Impact factor: 3.275

2.  Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.

Authors:  F Keller; M Maiga; H H Neumayer; H Lode; A Distler
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jul-Sep       Impact factor: 2.441

Review 3.  Vasodilators.

Authors:  T T Zsotér
Journal:  Can Med Assoc J       Date:  1983-09-01       Impact factor: 8.262

Review 4.  Clinical pharmacokinetics of hydralazine.

Authors:  T M Ludden; J L McNay; A M Shepherd; M S Lin
Journal:  Clin Pharmacokinet       Date:  1982 May-Jun       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of the depot antipsychotics.

Authors:  M W Jann; L Ereshefsky; S R Saklad
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

6.  Pharmacokinetics of brotizolam in renal failure.

Authors:  J Evers; E Renner; W D Bechtel
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

Review 7.  Clinical pharmacokinetics of clonidine.

Authors:  D T Lowenthal; K M Matzek; T R MacGregor
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

Review 8.  Long-term depot antipsychotics. A risk-benefit assessment.

Authors:  T R Barnes; D A Curson
Journal:  Drug Saf       Date:  1994-06       Impact factor: 5.606

9.  Kinetics of morphine in patients with renal failure.

Authors:  J Säwe; I Odar-Cederlöf
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

10.  Nomogram for drug dosage adjustment in patients with renal failure.

Authors:  T D Bjornsson
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.